| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity | 9.31e-07 | 4 | 124 | 3 | GO:0001010 | |
| GeneOntologyMolecularFunction | microtubule binding | CENPF CEP290 SPAG6 CCDC88C MACO1 VASH2 CDK5RAP2 MTCL1 CCDC181 MX1 | 2.28e-05 | 308 | 124 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 3.43e-05 | 30 | 124 | 4 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 3.91e-05 | 31 | 124 | 4 | GO:0140033 | |
| GeneOntologyMolecularFunction | chromatin binding | NANOGP8 CENPF NANOG BRD3 MLH3 NANOGP1 SUPT6H NR5A2 FOXP1 MLLT6 POLQ NIPBL GABPA CREB3 HELLS | 5.48e-05 | 739 | 124 | 15 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | HDAC9 NANOGP8 FOXP2 RB1 CENPF SETD6 NANOG NANOGP1 NR5A2 FOXP1 CNOT1 TXLNG CREB3 PROX1 | 2.45e-04 | 753 | 124 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | tubulin binding | CENPF CEP290 SPAG6 CCDC88C MACO1 VASH2 CDK5RAP2 MTCL1 CCDC181 MX1 | 3.42e-04 | 428 | 124 | 10 | GO:0015631 |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 3.78e-04 | 5 | 124 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 3.78e-04 | 5 | 124 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 3.78e-04 | 5 | 124 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.91e-04 | 230 | 124 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 6.84e-04 | 28 | 124 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 1.05e-03 | 8 | 124 | 2 | GO:0004723 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | IQGAP2 MYO5B CENPF CEP290 TWF2 SPAG6 CCDC88C TTBK1 MACO1 VASH2 CDK5RAP2 MICAL3 MTCL1 CCDC181 SCIN MX1 | 1.28e-03 | 1099 | 124 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 ABCC4 MYO5B ATP6V1H MLH3 ACIN1 DHX32 POLQ DNAH9 SMC1B HELLS | 1.56e-03 | 614 | 124 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.74e-03 | 441 | 124 | 9 | GO:0016887 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell fate specification | 7.65e-07 | 4 | 120 | 3 | GO:0042664 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell fate specification | 1.90e-06 | 5 | 120 | 3 | GO:0042663 | |
| GeneOntologyBiologicalProcess | negative regulation of endodermal cell differentiation | 3.79e-06 | 6 | 120 | 3 | GO:1903225 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.04e-05 | 237 | 120 | 9 | GO:0019827 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate specification | 1.05e-05 | 8 | 120 | 3 | GO:0009996 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.23e-05 | 242 | 120 | 9 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of endodermal cell differentiation | 2.24e-05 | 10 | 120 | 3 | GO:1903224 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 3.06e-05 | 11 | 120 | 3 | GO:0001714 | |
| GeneOntologyBiologicalProcess | negative regulation of lung goblet cell differentiation | 3.36e-05 | 2 | 120 | 2 | GO:1901250 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SPATA7 DNHD1 SLK CEP290 APOB CNTLN SGO1 SPAG6 KIAA0753 WDR47 CCDC88C AKAP9 SENP6 CDK5RAP2 MTCL1 ANKFN1 DNAH9 CFAP53 | 3.99e-05 | 1058 | 120 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | mucociliary clearance | 5.26e-05 | 13 | 120 | 3 | GO:0120197 | |
| GeneOntologyBiologicalProcess | endodermal cell differentiation | 6.90e-05 | 38 | 120 | 4 | GO:0035987 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SPATA7 SLK CEP290 CNTLN SGO1 SPAG6 KIAA0753 WDR47 CCDC88C AKAP9 SENP6 CDK5RAP2 MTCL1 ANKFN1 | 7.72e-05 | 720 | 120 | 14 | GO:0000226 |
| GeneOntologyBiologicalProcess | cell dedifferentiation | 8.30e-05 | 15 | 120 | 3 | GO:0043697 | |
| GeneOntologyBiologicalProcess | dedifferentiation | 8.30e-05 | 15 | 120 | 3 | GO:0043696 | |
| GeneOntologyBiologicalProcess | regulation of lung goblet cell differentiation | 1.00e-04 | 3 | 120 | 2 | GO:1901249 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 1.00e-04 | 3 | 120 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | negative regulation of cell fate commitment | 1.23e-04 | 17 | 120 | 3 | GO:0010454 | |
| GeneOntologyBiologicalProcess | brain development | FOXP2 CENPF CEP290 ZSWIM6 CCDC141 SPAG6 AMIGO1 WDR47 TTBK1 SUDS3 MACO1 CDK5RAP2 FOXP1 NIPBL PROX1 | 1.40e-04 | 859 | 120 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.47e-04 | 18 | 120 | 3 | GO:0001711 | |
| GeneOntologyBiologicalProcess | regulation of stem cell division | 1.47e-04 | 18 | 120 | 3 | GO:2000035 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 1.67e-04 | 266 | 120 | 8 | GO:0043270 | |
| GeneOntologyBiologicalProcess | endoderm formation | 1.89e-04 | 49 | 120 | 4 | GO:0001706 | |
| GeneOntologyBiologicalProcess | pancreas morphogenesis | 2.00e-04 | 4 | 120 | 2 | GO:0061113 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 2.04e-04 | 20 | 120 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | striatum development | 2.73e-04 | 22 | 120 | 3 | GO:0021756 | |
| GeneOntologyBiologicalProcess | head development | FOXP2 CENPF CEP290 ZSWIM6 CCDC141 SPAG6 AMIGO1 WDR47 TTBK1 SUDS3 MACO1 CDK5RAP2 FOXP1 NIPBL PROX1 | 2.90e-04 | 919 | 120 | 15 | GO:0060322 |
| GeneOntologyBiologicalProcess | mesodermal cell fate commitment | 3.12e-04 | 23 | 120 | 3 | GO:0001710 | |
| GeneOntologyBiologicalProcess | acinar cell differentiation | 3.32e-04 | 5 | 120 | 2 | GO:0090425 | |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 3.87e-04 | 59 | 120 | 4 | GO:0003351 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SLK IQGAP2 MYO5B RB1 TWF2 SPAG6 CYFIP2 WDR47 CCDC88C AKAP9 CDK5RAP2 MICAL3 SCIN CRTAP PROX1 | 4.44e-04 | 957 | 120 | 15 | GO:0097435 |
| GeneOntologyBiologicalProcess | extracellular transport | 4.68e-04 | 62 | 120 | 4 | GO:0006858 | |
| GeneOntologyBiologicalProcess | lung goblet cell differentiation | 4.96e-04 | 6 | 120 | 2 | GO:0060480 | |
| GeneOntologyBiologicalProcess | regulation of centromere complex assembly | 4.96e-04 | 6 | 120 | 2 | GO:0090230 | |
| GeneOntologyBiologicalProcess | subpallium development | 5.66e-04 | 28 | 120 | 3 | GO:0021544 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | IQGAP2 TWF2 CYFIP2 WDR47 CCDC88C AKAP9 SENP6 CDK5RAP2 SCIN PLXNB1 PROX1 | 5.69e-04 | 579 | 120 | 11 | GO:0051493 |
| GeneOntologyBiologicalProcess | embryo development | NANOGP8 FOXP2 NANOG CEP290 APOB BRD3 FOXP4 NANOGP1 SUDS3 SUPT6H VASH2 NR5A2 MCRS1 FOXP1 SENP2 CNOT1 NIPBL GABPA PROX1 | 6.26e-04 | 1437 | 120 | 19 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of cell fate specification | 6.28e-04 | 29 | 120 | 3 | GO:0042659 | |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 6.28e-04 | 29 | 120 | 3 | GO:0048745 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 6.29e-04 | 67 | 120 | 4 | GO:0007062 | |
| GeneOntologyBiologicalProcess | cell cycle process | NANOGP8 IQGAP2 RB1 CENPF CNTLN SGO1 KIAA0753 MLH3 PPP3CA SENP6 CDK5RAP2 SENP2 MTCL1 ANKFN1 TXLNG PMF1 NIPBL SMC1B PROX1 | 6.48e-04 | 1441 | 120 | 19 | GO:0022402 |
| GeneOntologyBiologicalProcess | lobar bronchus epithelium development | 6.92e-04 | 7 | 120 | 2 | GO:0060481 | |
| GeneOntologyBiologicalProcess | centromere complex assembly | 6.95e-04 | 30 | 120 | 3 | GO:0034508 | |
| GeneOntologyBiologicalProcess | cell division | NANOGP8 IQGAP2 RB1 CENPF NANOG SGO1 SPAG6 NANOGP1 MICAL3 MTCL1 PMF1 HELLS | 7.61e-04 | 697 | 120 | 12 | GO:0051301 |
| GeneOntologyCellularComponent | condensed chromosome | NANOGP8 CENPF NANOG SGO1 MLH3 NANOGP1 MTCL1 DCTN4 PMF1 SMC1B | 1.40e-05 | 307 | 123 | 10 | GO:0000793 |
| GeneOntologyCellularComponent | spindle | RB1 CENPF CEP162 SGO1 CDK5RAP2 MICAL3 MTCL1 DCTN4 ANKFN1 CFAP53 PMF1 | 1.08e-04 | 471 | 123 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | spindle pole | 2.14e-04 | 205 | 123 | 7 | GO:0000922 | |
| GeneOntologyCellularComponent | axoneme | 2.27e-04 | 207 | 123 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.34e-04 | 208 | 123 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | calcineurin complex | 5.07e-04 | 6 | 123 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.27e-04 | 238 | 123 | 7 | GO:0097729 | |
| GeneOntologyCellularComponent | manchette | 5.85e-04 | 28 | 123 | 3 | GO:0002177 | |
| GeneOntologyCellularComponent | centrosome | CENPF CEP162 CEP290 CNTLN SGO1 CCDC141 KIAA0753 CCDC88C AKAP9 CCDC15 CDK5RAP2 DCTN4 CFAP53 | 6.14e-04 | 770 | 123 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | photoreceptor distal connecting cilium | 7.07e-04 | 7 | 123 | 2 | GO:0120206 | |
| GeneOntologyCellularComponent | microtubule organizing center | SPATA7 CENPF CEP162 CEP290 CNTLN SGO1 CCDC141 KIAA0753 CCDC88C AKAP9 CCDC15 CDK5RAP2 DCTN4 CFAP53 | 1.03e-03 | 919 | 123 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | rod photoreceptor outer segment | 1.20e-03 | 9 | 123 | 2 | GO:0120200 | |
| GeneOntologyCellularComponent | microtubule | IQGAP2 CEP162 SPAG6 WDR47 CDK5RAP2 MTCL1 CCDC181 DNAH9 CFAP53 MX1 | 1.22e-03 | 533 | 123 | 10 | GO:0005874 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.25e-03 | 276 | 123 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.32e-03 | 360 | 123 | 8 | GO:0099568 | |
| MousePheno | absent primitive endoderm | 2.35e-07 | 9 | 94 | 4 | MP:0011185 | |
| MousePheno | absent embryonic epiblast | 3.28e-06 | 16 | 94 | 4 | MP:0011184 | |
| MousePheno | abnormal primitive endoderm morphology | 1.84e-05 | 24 | 94 | 4 | MP:0011183 | |
| Domain | FOXP-CC | 1.08e-06 | 4 | 122 | 3 | PF16159 | |
| Domain | FOXP-CC | 1.08e-06 | 4 | 122 | 3 | IPR032354 | |
| Domain | PP2Ac | 7.41e-05 | 13 | 122 | 3 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 7.41e-05 | 13 | 122 | 3 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 7.41e-05 | 13 | 122 | 3 | PS00125 | |
| Domain | Metallophos | 7.91e-04 | 28 | 122 | 3 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 7.91e-04 | 28 | 122 | 3 | IPR004843 | |
| Domain | Peptidase_C48_C | 8.70e-04 | 7 | 122 | 2 | IPR003653 | |
| Domain | Peptidase_C48 | 8.70e-04 | 7 | 122 | 2 | PF02902 | |
| Domain | ULP_PROTEASE | 8.70e-04 | 7 | 122 | 2 | PS50600 | |
| Domain | Metallo-depent_PP-like | 9.71e-04 | 30 | 122 | 3 | IPR029052 | |
| Domain | - | 9.71e-04 | 30 | 122 | 3 | 3.60.21.10 | |
| Domain | IQ | 1.20e-03 | 71 | 122 | 4 | PF00612 | |
| Domain | ZF_SWIM | 1.48e-03 | 9 | 122 | 2 | PS50966 | |
| Domain | Znf_SWIM | 1.48e-03 | 9 | 122 | 2 | IPR007527 | |
| Domain | IQ | 1.96e-03 | 81 | 122 | 4 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.87e-03 | 90 | 122 | 4 | IPR000048 | |
| Domain | IQ | 3.23e-03 | 93 | 122 | 4 | PS50096 | |
| Domain | TF_fork_head_CS_2 | 3.36e-03 | 46 | 122 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 3.58e-03 | 47 | 122 | 3 | IPR018122 | |
| Domain | Dynein_HC_stalk | 3.66e-03 | 14 | 122 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.66e-03 | 14 | 122 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.66e-03 | 14 | 122 | 2 | PF08393 | |
| Domain | MT | 3.66e-03 | 14 | 122 | 2 | PF12777 | |
| Domain | FH | 4.02e-03 | 49 | 122 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 4.02e-03 | 49 | 122 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 4.02e-03 | 49 | 122 | 3 | PS00658 | |
| Domain | Fork_head_dom | 4.02e-03 | 49 | 122 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 4.02e-03 | 49 | 122 | 3 | PS50039 | |
| Domain | Forkhead | 4.02e-03 | 49 | 122 | 3 | PF00250 | |
| Domain | DHC_fam | 4.20e-03 | 15 | 122 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.20e-03 | 15 | 122 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.20e-03 | 15 | 122 | 2 | IPR004273 | |
| Domain | RasGAP_dom | 6.05e-03 | 18 | 122 | 2 | IPR001936 | |
| Pubmed | PDPR MYO5B ARHGAP10 CEP162 CEP290 BRD3 PPEF2 SGO1 CYFIP2 KIAA0753 PHKA1 PPP3CA PPP3CC AKAP9 MACO1 CDK5RAP2 SENP2 MICAL3 SCIN CNOT1 HELLS | 2.40e-10 | 1049 | 127 | 21 | 27880917 | |
| Pubmed | LRH-1 and Nanog regulate Dax1 transcription in mouse embryonic stem cells. | 8.45e-10 | 5 | 127 | 4 | 20937355 | |
| Pubmed | MCRS1 is essential for epiblast development during early mouse embryogenesis. | 2.53e-09 | 6 | 127 | 4 | 31671403 | |
| Pubmed | HDAC9 STIM2 MYO5B CEP290 ZFC3H1 AMIGO1 KIAA0753 CCDC88C UBE4A TTBK1 MICAL3 PLCH1 SCIN PDZRN3 | 3.96e-09 | 493 | 127 | 14 | 15368895 | |
| Pubmed | SLK LZTS3 FOXP2 IQGAP2 CENPF EDC4 TTC3 CYFIP2 WDR47 CCDC88C PPP3CA AKAP9 CDK5RAP2 MTCL1 CNOT1 NIPBL GOLGB1 PROX1 | 1.50e-08 | 963 | 127 | 18 | 28671696 | |
| Pubmed | Lineage regulators TFAP2C and NR5A2 function as bipotency activators in totipotent embryos. | 2.11e-08 | 9 | 127 | 4 | 38243114 | |
| Pubmed | The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1. | 4.76e-08 | 3 | 127 | 3 | 30814124 | |
| Pubmed | Multiple phases in regulation of Nanog expression during pre-implantation development. | 4.76e-08 | 3 | 127 | 3 | 26660234 | |
| Pubmed | Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog. | 4.76e-08 | 3 | 127 | 3 | 18177668 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 14516685 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24929238 | ||
| Pubmed | Nanog and transcriptional networks in embryonic stem cell pluripotency. | 4.76e-08 | 3 | 127 | 3 | 17211451 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 15502159 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 20574542 | ||
| Pubmed | lincRNAs act in the circuitry controlling pluripotency and differentiation. | 4.76e-08 | 3 | 127 | 3 | 21874018 | |
| Pubmed | Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations. | 4.76e-08 | 3 | 127 | 3 | 23054952 | |
| Pubmed | CrxOS maintains the self-renewal capacity of murine embryonic stem cells. | 4.76e-08 | 3 | 127 | 3 | 19800316 | |
| Pubmed | Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog. | 4.76e-08 | 3 | 127 | 3 | 26975336 | |
| Pubmed | Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3. | 4.76e-08 | 3 | 127 | 3 | 23329853 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23665121 | ||
| Pubmed | Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts. | 4.76e-08 | 3 | 127 | 3 | 26733157 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16501172 | ||
| Pubmed | Human-specific transcriptional regulation of CNS development genes by FOXP2. | 4.76e-08 | 3 | 127 | 3 | 19907493 | |
| Pubmed | Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. | 4.76e-08 | 3 | 127 | 3 | 19582141 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 19703398 | ||
| Pubmed | Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology. | 4.76e-08 | 3 | 127 | 3 | 28636920 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 20539761 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 18584034 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21969378 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 20661723 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 29245050 | ||
| Pubmed | Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. | 4.76e-08 | 3 | 127 | 3 | 15494369 | |
| Pubmed | Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. | 4.76e-08 | 3 | 127 | 3 | 14728807 | |
| Pubmed | Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. | 4.76e-08 | 3 | 127 | 3 | 21194951 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 22388986 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16791199 | ||
| Pubmed | Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells. | 4.76e-08 | 3 | 127 | 3 | 18024963 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 27125671 | ||
| Pubmed | Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells. | 4.76e-08 | 3 | 127 | 3 | 25410303 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 33334884 | ||
| Pubmed | Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder. | 4.76e-08 | 3 | 127 | 3 | 17360937 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 26760119 | ||
| Pubmed | Nanog is dispensable for the generation of induced pluripotent stem cells. | 4.76e-08 | 3 | 127 | 3 | 24461999 | |
| Pubmed | Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing. | 4.76e-08 | 3 | 127 | 3 | 30837263 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 25173648 | ||
| Pubmed | Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function. | 4.76e-08 | 3 | 127 | 3 | 27939294 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 18442017 | ||
| Pubmed | Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization. | 4.76e-08 | 3 | 127 | 3 | 25027557 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16790525 | ||
| Pubmed | Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling. | 4.76e-08 | 3 | 127 | 3 | 22172669 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 19447925 | ||
| Pubmed | The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells. | 4.76e-08 | 3 | 127 | 3 | 30846691 | |
| Pubmed | Generation of germline-competent induced pluripotent stem cells. | 4.76e-08 | 3 | 127 | 3 | 17554338 | |
| Pubmed | Expression of Nanog gene promotes NIH3T3 cell proliferation. | 4.76e-08 | 3 | 127 | 3 | 16259959 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 12609610 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24227785 | ||
| Pubmed | The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. | 4.76e-08 | 3 | 127 | 3 | 23770853 | |
| Pubmed | Nanog-independent reprogramming to iPSCs with canonical factors. | 4.76e-08 | 3 | 127 | 3 | 24527385 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 18086680 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 17204467 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23200040 | ||
| Pubmed | NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers. | 4.76e-08 | 3 | 127 | 3 | 26751055 | |
| Pubmed | Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. | 4.76e-08 | 3 | 127 | 3 | 17352742 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23178592 | ||
| Pubmed | Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency. | 4.76e-08 | 3 | 127 | 3 | 25005472 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16773043 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 23071603 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21119109 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 32145514 | ||
| Pubmed | Nanog safeguards pluripotency and mediates germline development. | 4.76e-08 | 3 | 127 | 3 | 18097409 | |
| Pubmed | Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst. | 4.76e-08 | 3 | 127 | 3 | 25753417 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 22337995 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 18290762 | ||
| Pubmed | Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog. | 4.76e-08 | 3 | 127 | 3 | 23333380 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 28507505 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 25825768 | ||
| Pubmed | Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation. | 4.76e-08 | 3 | 127 | 3 | 31891567 | |
| Pubmed | Isolation and characterization of the murine Nanog gene promoter. | 4.76e-08 | 3 | 127 | 3 | 15916719 | |
| Pubmed | Nanog retrotransposed genes with functionally conserved open reading frames. | 4.76e-08 | 3 | 127 | 3 | 16845474 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 16313224 | ||
| Pubmed | Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6. | 4.76e-08 | 3 | 127 | 3 | 33665763 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 22028025 | ||
| Pubmed | Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming. | 4.76e-08 | 3 | 127 | 3 | 28457890 | |
| Pubmed | Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. | 4.76e-08 | 3 | 127 | 3 | 18436640 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21499299 | ||
| Pubmed | Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal. | 4.76e-08 | 3 | 127 | 3 | 33107035 | |
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 35976266 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 24681518 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 26549484 | ||
| Pubmed | 4.76e-08 | 3 | 127 | 3 | 21187909 | ||
| Pubmed | Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter. | 4.76e-08 | 3 | 127 | 3 | 16541131 | |
| Pubmed | Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration. | 4.76e-08 | 3 | 127 | 3 | 22142851 | |
| Pubmed | NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program. | 4.76e-08 | 3 | 127 | 3 | 24462001 | |
| Pubmed | Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. | 4.76e-08 | 3 | 127 | 3 | 23103910 | |
| Pubmed | Nr5a2 is dispensable for zygotic genome activation but essential for morula development. | 5.49e-08 | 11 | 127 | 4 | 39361745 | |
| Pubmed | MED20 SLK RB1 CEP162 CEP290 BRD3 EDC4 SGO1 KIAA0753 ATP6V1H MICAL3 CNOT1 TXLNG HELLS | 1.12e-07 | 645 | 127 | 14 | 25281560 | |
| Pubmed | STRA8-RB interaction is required for timely entry of meiosis in mouse female germ cells. | 1.65e-07 | 14 | 127 | 4 | 37880249 | |
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 22315219 | ||
| Pubmed | 1.90e-07 | 4 | 127 | 3 | 14701752 | ||
| Pubmed | USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency. | 1.90e-07 | 4 | 127 | 3 | 29263902 | |
| Interaction | CEP135 interactions | LZTS3 CEP162 CEP290 CNTLN KIAA0753 CCDC88C AKAP9 MACO1 CCDC15 CDK5RAP2 CNOT1 TXLNG GOLGB1 | 8.10e-09 | 272 | 119 | 13 | int:CEP135 |
| Interaction | BNC2 interactions | 8.17e-09 | 13 | 119 | 5 | int:BNC2 | |
| Interaction | KRT8 interactions | CEP162 PPEF2 TTC3 KIAA0753 MTRF1 AKAP9 ZNF804B SCN4A CDK5RAP2 MTCL1 CNOT1 PDZRN3 | 1.19e-05 | 441 | 119 | 12 | int:KRT8 |
| Interaction | MED4 interactions | MED20 SLK CEP162 CEP290 BRD3 EDC4 KIAA0753 POLR3B MCRS1 MICAL3 CNOT1 TXLNG | 1.46e-05 | 450 | 119 | 12 | int:MED4 |
| Interaction | NDC80 interactions | RB1 CEP162 CEP290 CNTLN KIAA0753 AKAP9 CDK5RAP2 MTCL1 TXLNG PMF1 | 1.64e-05 | 312 | 119 | 10 | int:NDC80 |
| Interaction | PCM1 interactions | CEP162 CEP290 CNTLN TTC3 DENND1A KIAA0753 AKAP9 CDK5RAP2 MCRS1 TXLNG PDZRN3 | 5.33e-05 | 434 | 119 | 11 | int:PCM1 |
| Interaction | MAPRE3 interactions | 6.74e-05 | 230 | 119 | 8 | int:MAPRE3 | |
| Interaction | TOX interactions | 6.97e-05 | 14 | 119 | 3 | int:TOX | |
| Interaction | NFAT5 interactions | 7.30e-05 | 38 | 119 | 4 | int:NFAT5 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.31e-05 | 13 | 80 | 3 | 693 | |
| GeneFamily | SUMO specific peptidases | 4.00e-04 | 7 | 80 | 2 | 984 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 6.82e-04 | 9 | 80 | 2 | 90 | |
| GeneFamily | Forkhead boxes | 9.06e-04 | 43 | 80 | 3 | 508 | |
| Coexpression | LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED | 5.59e-10 | 38 | 126 | 7 | M39244 | |
| Coexpression | TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN | 1.27e-05 | 10 | 126 | 3 | MM741 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 DIRAS1 MYO5B RB1 CENPF ZSWIM5 CEP162 CEP290 CYFIP2 WDR47 CCDC88C AKAP9 CCDC15 DHX32 MICAL3 MTCL1 CCDC181 PLCH1 POLQ NIPBL PROX1 | 1.31e-07 | 989 | 119 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 PDPR FOXP2 IQGAP2 CENPF ZSWIM5 CEP162 CEP290 CNTLN SGO1 CYFIP2 WDR47 CCDC88C AKAP9 CCDC15 DHX32 PLCH1 NIPBL PROX1 HELLS | 1.71e-06 | 1060 | 119 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | MYO5B CENPF CEP290 ZSWIM6 SGO1 TTC3 CYFIP2 MACO1 ACIN1 MICAL3 POLQ CNOT1 TXLNG NIPBL | 1.72e-06 | 532 | 119 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 PDPR FOXP2 IQGAP2 CENPF ZSWIM5 CEP162 CEP290 CNTLN SGO1 CYFIP2 WDR47 CCDC88C AKAP9 CCDC15 DHX32 MARVELD3 PLCH1 ANKFN1 NIPBL PROX1 HELLS | 1.11e-05 | 1414 | 119 | 22 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | DIRAS1 RB1 ZSWIM5 CYFIP2 CCDC88C ATP6V1H MACO1 CCDC15 ACIN1 TXLNG PROX1 | 1.40e-05 | 395 | 119 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 1.89e-05 | 98 | 119 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CENPF ZNF569 ZSWIM5 CEP162 CEP290 ZSWIM6 ZFC3H1 SGO1 TTC3 AMIGO1 CYFIP2 CCDC88C FOXP4 AKAP9 CCDC15 DHX32 PLCH1 ANKFN1 NIPBL PROX1 HELLS | 2.26e-05 | 1370 | 119 | 21 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RB1 CENPF ZSWIM5 CEP290 CYFIP2 CCDC88C AKAP9 MTCL1 PLCH1 POLQ NIPBL PROX1 | 2.37e-05 | 498 | 119 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.83e-05 | 231 | 119 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RB1 CENPF CEP162 CEP290 CYFIP2 WDR47 AKAP9 CCDC15 DHX32 MICAL3 DCTN4 CCDC181 POLQ NIPBL FBXO34 | 6.38e-05 | 831 | 119 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | 7.95e-05 | 396 | 119 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 1.06e-04 | 192 | 119 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | MYO5B RB1 PHLDA1 ZSWIM5 CYFIP2 CCDC88C DHX32 MTCL1 PLCH1 NIPBL PLXNB1 | 1.08e-04 | 495 | 119 | 11 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | SPATA7 SLK DIRAS1 IQGAP2 RB1 ZSWIM5 STEAP2 CYFIP2 CCDC88C UBE4A SUPT6H CDK5RAP2 DHX32 PLCH1 GOLGB1 PROX1 | 1.15e-04 | 979 | 119 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | DIRAS1 RB1 CENPF ZSWIM5 CEP290 CNTLN CYFIP2 CCDC88C FOXP4 AKAP9 DHX32 PLCH1 NIPBL PDZRN3 PLXNB1 PROX1 | 1.25e-04 | 986 | 119 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 SLK PDPR RB1 CYFIP2 UBE4A SUPT6H CCDC15 SENP6 CDK5RAP2 DHX32 GOLGB1 | 1.30e-04 | 595 | 119 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 SLK FOXP2 CEP290 CNTLN STEAP2 UBE4A CDK5RAP2 NIPBL GOLGB1 | 1.62e-04 | 432 | 119 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | ABCC4 MYO5B CENPF ZSWIM5 NANOG CEP290 SRM ZSWIM6 SGO1 CYFIP2 CCDC88C AKAP9 FLAD1 MTCL1 PLCH1 ANKFN1 PMF1 PROX1 HELLS | 1.74e-04 | 1347 | 119 | 19 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 SLK CENPF CEP290 CNTLN UBE4A AKAP9 SUPT6H CCDC15 CDK5RAP2 NIPBL GOLGB1 | 2.18e-04 | 629 | 119 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.79e-04 | 298 | 119 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000 | MYO5B PHLDA1 CENPF ZSWIM5 CCDC88C FOXP4 POLR3B INTS2 FLAD1 MCRS1 MTCL1 PLCH1 POLQ GABPA PROX1 | 4.32e-04 | 991 | 119 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | DIRAS1 MYO5B CENPF ZSWIM5 CEP290 CYFIP2 CCDC88C AKAP9 DHX32 PLCH1 | 4.62e-04 | 493 | 119 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.84e-09 | 198 | 127 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.01e-07 | 197 | 127 | 8 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.09e-07 | 199 | 127 | 8 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-07 | 165 | 127 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.34e-06 | 192 | 127 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.44e-06 | 194 | 127 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.59e-06 | 197 | 127 | 7 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.64e-06 | 198 | 127 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.70e-06 | 199 | 127 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.70e-06 | 199 | 127 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.70e-06 | 199 | 127 | 7 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.36e-06 | 154 | 127 | 6 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.21e-06 | 158 | 127 | 6 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.21e-06 | 158 | 127 | 6 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.21e-06 | 158 | 127 | 6 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.69e-06 | 164 | 127 | 6 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.12e-06 | 169 | 127 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-05 | 176 | 127 | 6 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-05 | 176 | 127 | 6 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.27e-05 | 179 | 127 | 6 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 179 | 127 | 6 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 180 | 127 | 6 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 180 | 127 | 6 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-05 | 180 | 127 | 6 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 186 | 127 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.62e-05 | 187 | 127 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 1.62e-05 | 187 | 127 | 6 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-05 | 188 | 127 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-05 | 189 | 127 | 6 | 3717d1148e26ac78a26aea0ca1dbfbb9d3668877 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.72e-05 | 189 | 127 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 190 | 127 | 6 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 1.83e-05 | 191 | 127 | 6 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 1.83e-05 | 191 | 127 | 6 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.88e-05 | 192 | 127 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.88e-05 | 192 | 127 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.94e-05 | 193 | 127 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.99e-05 | 194 | 127 | 6 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.05e-05 | 195 | 127 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-05 | 195 | 127 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.11e-05 | 196 | 127 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.17e-05 | 197 | 127 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.17e-05 | 197 | 127 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.24e-05 | 198 | 127 | 6 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 2.30e-05 | 199 | 127 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.30e-05 | 199 | 127 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.30e-05 | 199 | 127 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.30e-05 | 199 | 127 | 6 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 127 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 200 | 127 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 127 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-05 | 200 | 127 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 127 | 6 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 200 | 127 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-05 | 200 | 127 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.37e-05 | 200 | 127 | 6 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | (18)_cycling_gd_T|World / shred on Cell_type and subtype | 2.57e-05 | 203 | 127 | 6 | 7d58929058c4769226a29febee1fd8ba64bc9f1a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.44e-05 | 129 | 127 | 5 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.00e-05 | 154 | 127 | 5 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.50e-05 | 156 | 127 | 5 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 8.50e-05 | 156 | 127 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.50e-05 | 156 | 127 | 5 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.76e-05 | 157 | 127 | 5 | 1e3a4a7193d95f09d71c2dfe704b8e626c6d9624 | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 9.30e-05 | 159 | 127 | 5 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.02e-04 | 162 | 127 | 5 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.02e-04 | 162 | 127 | 5 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-04 | 164 | 127 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 164 | 127 | 5 | 9e16e52f5a634585f26021bcce9b5d5992ff6db0 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 165 | 127 | 5 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 165 | 127 | 5 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.17e-04 | 167 | 127 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 167 | 127 | 5 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.20e-04 | 168 | 127 | 5 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 168 | 127 | 5 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | COVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 170 | 127 | 5 | e90f18e5462381b38e918442b38b1c8105291908 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 170 | 127 | 5 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 170 | 127 | 5 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.31e-04 | 171 | 127 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 171 | 127 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 171 | 127 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-04 | 172 | 127 | 5 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.34e-04 | 172 | 127 | 5 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 1.38e-04 | 173 | 127 | 5 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 173 | 127 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 175 | 127 | 5 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 175 | 127 | 5 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 175 | 127 | 5 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 176 | 127 | 5 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 176 | 127 | 5 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 176 | 127 | 5 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.54e-04 | 177 | 127 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 178 | 127 | 5 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 178 | 127 | 5 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.58e-04 | 178 | 127 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 178 | 127 | 5 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-04 | 178 | 127 | 5 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.58e-04 | 178 | 127 | 5 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| Drug | Clorgyline | 3.35e-07 | 168 | 123 | 9 | ctd:D003010 | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.22e-06 | 196 | 123 | 9 | 4619_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A | 7.29e-06 | 184 | 123 | 8 | 2669_UP | |
| Disease | specific developmental disorder (implicated_via_orthology) | 2.89e-07 | 4 | 124 | 3 | DOID:0060038 (implicated_via_orthology) | |
| Disease | colon cancer (implicated_via_orthology) | 1.17e-05 | 11 | 124 | 3 | DOID:219 (implicated_via_orthology) | |
| Disease | precuneus cortex volume measurement | 2.55e-05 | 14 | 124 | 3 | EFO_0010326 | |
| Disease | Dyslipidemias | 1.37e-04 | 24 | 124 | 3 | C0242339 | |
| Disease | childhood trauma measurement | 1.37e-04 | 24 | 124 | 3 | EFO_0007979 | |
| Disease | Dyslipoproteinemias | 1.37e-04 | 24 | 124 | 3 | C0598784 | |
| Disease | Malignant neoplasm of breast | RB1 CENPF ZNF569 ZSWIM5 TP53I3 TTC3 SPAG6 FOXP4 AKAP9 DHX32 DNAH9 NIPBL PLXNB1 GOLGB1 | 1.74e-04 | 1074 | 124 | 14 | C0006142 |
| Disease | anorexia nervosa | 2.20e-04 | 70 | 124 | 4 | MONDO_0005351 | |
| Disease | QT interval | 4.39e-04 | 534 | 124 | 9 | EFO_0004682 | |
| Disease | holoprosencephaly (is_implicated_in) | 4.82e-04 | 8 | 124 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Intestinal Diseases | 4.82e-04 | 8 | 124 | 2 | C0021831 | |
| Disease | forced expiratory volume | HDAC9 CNTLN CYFIP2 KIAA0753 SCN4A NR5A2 FOXP1 MICAL3 MTCL1 ANKFN1 TXLNG | 5.10e-04 | 789 | 124 | 11 | EFO_0004314 |
| Disease | Situs ambiguous | 6.19e-04 | 9 | 124 | 2 | C1167664 | |
| Disease | Carcinoma, Small Cell | 6.19e-04 | 9 | 124 | 2 | C0262584 | |
| Disease | coronary artery calcification | 6.48e-04 | 450 | 124 | 8 | EFO_0004723 | |
| Disease | gastroesophageal reflux disease | 8.86e-04 | 101 | 124 | 4 | EFO_0003948 | |
| Disease | Situs Inversus | 9.40e-04 | 11 | 124 | 2 | C0037221 | |
| Disease | campesterol measurement | 9.40e-04 | 11 | 124 | 2 | EFO_0020008 | |
| Disease | fatty acid measurement, fetal genotype effect measurement, breast milk measurement | 1.33e-03 | 13 | 124 | 2 | EFO_0005110, EFO_0007959, EFO_0009092 | |
| Disease | fatty acid measurement, breast milk measurement, parental genotype effect measurement | 1.54e-03 | 14 | 124 | 2 | EFO_0005110, EFO_0005939, EFO_0009092 | |
| Disease | Situs ambiguus | 1.77e-03 | 15 | 124 | 2 | C0266642 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 1.77e-03 | 15 | 124 | 2 | EFO_0004791, HP_0002140 | |
| Disease | Leber congenital amaurosis | 2.02e-03 | 16 | 124 | 2 | cv:C0339527 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 2.02e-03 | 16 | 124 | 2 | EFO_0004792, HP_0002140 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 2.08e-03 | 60 | 124 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | factor XI measurement, Ischemic stroke | 2.29e-03 | 17 | 124 | 2 | EFO_0004694, HP_0002140 | |
| Disease | eye colour measurement | 2.32e-03 | 218 | 124 | 5 | EFO_0009764 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 2.56e-03 | 18 | 124 | 2 | C0342384 | |
| Disease | insomnia measurement | 2.74e-03 | 443 | 124 | 7 | EFO_0007876 | |
| Disease | neuroticism measurement, cognitive function measurement | 2.75e-03 | 566 | 124 | 8 | EFO_0007660, EFO_0008354 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.86e-03 | 19 | 124 | 2 | EFO_0004630, HP_0002140 | |
| Disease | taurocholate measurement | 3.17e-03 | 20 | 124 | 2 | EFO_0010538 | |
| Disease | adenosine diphosphate measurement | 3.17e-03 | 20 | 124 | 2 | EFO_0010452 | |
| Disease | Leber Congenital Amaurosis | 3.83e-03 | 22 | 124 | 2 | C0339527 | |
| Disease | behavioural disinhibition measurement | 3.92e-03 | 75 | 124 | 3 | EFO_0006946 | |
| Disease | Headache, type 2 diabetes mellitus | 4.18e-03 | 23 | 124 | 2 | HP_0002315, MONDO_0005148 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSQNSFIKQYLEKQQ | 131 | Q9UKV3 | |
| VVYQMIQQIQQKREL | 966 | P55198 | |
| TNQLQYMQNVVVKTL | 36 | Q15059 | |
| LLEYNIQQKQSQMLE | 3121 | Q99996 | |
| DMAQLQKLYLSQNQI | 156 | Q86WK6 | |
| SKNLEKAIQIMYQNL | 81 | Q9Y646 | |
| KAIQIMYQNLQQDGL | 86 | Q9Y646 | |
| LQMLQTNYRAVKEQL | 566 | Q9NXG0 | |
| TRFKIQQLLEPQQYM | 561 | Q9NWN3 | |
| ESYLLKMQQKLQNDL | 1171 | Q8IYA2 | |
| SMFQQQLEQSKLLYK | 3176 | Q96M86 | |
| KEKYSFMENLLQNQI | 66 | Q7L7V1 | |
| YKLQKEQNLNMQLFS | 1211 | Q96SN8 | |
| YNSVFMQRLKTNILQ | 756 | P06400 | |
| QLELQMTALRYQKKF | 206 | Q9UPQ7 | |
| NKYKQMLVNAFTEQI | 271 | Q53FA7 | |
| VQRKVLYVMELLQNQ | 426 | Q6P2E9 | |
| VMAQVRQKLFQFLQA | 1361 | Q6P2E9 | |
| MQQELRSLKQNIFLF | 1026 | Q9Y4B5 | |
| FNHYKMELQINIQNT | 221 | A1A4S6 | |
| NIYSKFLLTKMEQQQ | 76 | Q9NRZ9 | |
| VGNQNKVKYMATQLL | 716 | Q7RTP6 | |
| QKQLQLSYVEMYQRN | 616 | O60299 | |
| MLKIVNPRYQNQFAE | 66 | Q9BZ81 | |
| DQVNYQAMKLTLLQK | 326 | Q13201 | |
| LLRKYVLASQEQQMN | 246 | Q06546 | |
| DQQQFYLALDNKMIV | 526 | P46020 | |
| KTYYQEVLQQLIVMN | 86 | Q9P219 | |
| MNELERQFLKLINYN | 271 | Q5T2Q4 | |
| VQKENEFYMQLLQQA | 186 | Q8N5G2 | |
| TAQKMQLGYRLQQIA | 2111 | O43157 | |
| NKNMQFLFVNKRLVL | 246 | Q9UHC1 | |
| LQQKQNGVYKRLTMF | 756 | Q8NCN5 | |
| QAVMLQQQQLQEFYK | 126 | O15409 | |
| LMLQQQQLQEFYKKQ | 136 | Q9H334 | |
| KFVRQQKYTQNDLMI | 841 | Q9H0H0 | |
| LMFEQEVKNLYNNIL | 2206 | Q6KC79 | |
| NDRFQRQKYLSLQQM | 111 | Q9H9S0 | |
| AMTQQIYDKFIAQLQ | 71 | Q6P1K2 | |
| ALMLQQLQEYYKKQQ | 136 | Q8IVH2 | |
| QILNNEVFAILNKYM | 1236 | Q96F07 | |
| MLNPFIYTLRNQQVK | 281 | A6NM76 | |
| LLQNKESLFYKMVQQ | 1261 | O15439 | |
| YIMEKIVQANKLLQN | 126 | Q5TID7 | |
| QRLAQEYRKQLQMQI | 441 | Q96M91 | |
| EYRKQLQMQIAYQQQ | 446 | Q96M91 | |
| AKMNYNVKELFQELL | 151 | O95057 | |
| LGINLYELMKNNNFQ | 186 | Q9NR20 | |
| NFNEKLSQLQTYMIQ | 2166 | P04114 | |
| LEMAFIQKNLRQLNY | 156 | Q9NZS2 | |
| KPQFQQLNDEVQYIM | 731 | Q6ZP82 | |
| YVNNKLTLFRQLQQM | 106 | Q9H7D0 | |
| YNAQLVQLEAMLRNK | 1206 | P49454 | |
| IKVKEYNNLLNALQM | 856 | O15078 | |
| YLLFDQNDKVMQQNL | 321 | O75718 | |
| QMAQQVQELQPYKVL | 136 | P0CW27 | |
| VLIQNGSKNQNVYMK | 1171 | O75417 | |
| KVYNRQTIQVSLMQN | 151 | Q8IUK8 | |
| EQQFQKMKIQYEQRL | 991 | Q5TB80 | |
| QQLDVQFYQLKLPMV | 256 | Q96A59 | |
| QLMKQYYLLEDQTVQ | 256 | Q96EZ8 | |
| MRQFLQNATQLQLFK | 351 | Q8TEH3 | |
| QVQLQNLVMSKYVAF | 1476 | Q9NYC9 | |
| FLEKQKQYQQQIHMN | 471 | Q9UKV0 | |
| ESYLLKMQQKLQNDL | 1361 | A2RUR9 | |
| EQFLQDTIKRYNLQM | 446 | Q8NFF5 | |
| RVLKYTAQNMELQNK | 181 | O43889 | |
| TQRMNKLIEYYQQLA | 141 | Q9UJW0 | |
| VKQNLDFENQMLYTL | 331 | Q9ULB4 | |
| VLKYENNVMNIRQFN | 321 | Q08209 | |
| VTQQLLQKYNMQFLI | 471 | O14830 | |
| VQYMELFNKIRKQQQ | 191 | Q9H944 | |
| PQVQAKIMAYLQQEQ | 316 | O00482 | |
| INFYMNLLVERNKKQ | 416 | Q9HC62 | |
| QQVRYNALLAVQKLM | 446 | Q9UI12 | |
| MSQRQVLQVFEQYQK | 1 | O75602 | |
| KQLQNYLRSVMNKVI | 736 | Q8TEQ0 | |
| QLLKQQLKDQYFMQR | 1021 | Q9H2G2 | |
| NQSQLKVDILYNINM | 1376 | P35499 | |
| FLQQMNYSKNTQIQV | 316 | Q9Y6U3 | |
| NELFNLQKQNTMNYL | 346 | Q13576 | |
| EKVQLNIQDLLQMQY | 1531 | Q13576 | |
| NDRFQRQKYLSLQQM | 111 | Q6NSW7 | |
| MQKQLRQLQEKFYQI | 246 | Q92786 | |
| STLLKNYQDNNKMLV | 51 | Q5FBB7 | |
| EQQALQVRYGQKMIL | 451 | Q8TBK2 | |
| QLQQKLYLIQMIPRQ | 291 | Q9H5Q4 | |
| KILIDVSNNMRINQY | 111 | Q8NFT2 | |
| ARMLYVLQQQVKEIQ | 266 | Q2KHM9 | |
| MVLVNIIYFKGQRQN | 176 | Q96P15 | |
| FLTQLMQKEQRNYQF | 181 | Q15459 | |
| RQTIDQKINMLYNEL | 156 | O75570 | |
| QKINMLYNELFQSLV | 161 | O75570 | |
| MLNPFIYTLRNQQVK | 281 | Q9NZP0 | |
| ALRAQIQEKMQLYNI | 866 | Q0P6D6 | |
| YELQMAVKALLQQIN | 681 | Q8N957 | |
| KVMNTLLIQDIYQQQ | 856 | G9CGD6 | |
| FNKMVLNETYRNIKV | 1161 | A5YKK6 | |
| ALQQFLYVQMAKELK | 716 | Q7KZ85 | |
| AVLKYENNVMNIRQF | 316 | P48454 | |
| EQKEQQRQIYQQMLL | 441 | O94967 | |
| TLFQMNRDQLQKFIQ | 271 | Q9P217 | |
| QIFQQKRNYFMDISN | 791 | O75762 | |
| KFNYVVMQLQGRNLA | 101 | Q5TCY1 | |
| DKYKILQLQAQQHMQ | 1156 | A4D1E1 | |
| LKMNKIQLQLFQLYH | 216 | Q8NDV3 | |
| YNIKRQNAEMQLAIA | 366 | Q9P246 | |
| QRQTIFNISLMKLYN | 36 | Q14140 | |
| ITLQMVQYKNRQAIL | 276 | Q8WV24 | |
| KLQANQKFRYNELMQ | 1836 | Q15413 | |
| FLQRVKNMLIAFSQN | 206 | P22309 | |
| DPQKIKQLNLAMINY | 521 | P53804 | |
| PAVYQKLSIQLQMNK | 511 | Q9GZR1 | |
| QQERQQYQKALDMLL | 461 | Q9P0W8 | |
| LQAIQNYMKTLQYNH | 111 | Q86V25 | |
| QIFTQMQALKYIGNK | 276 | Q9NW08 | |
| LTQQQVAQMQLKYYN | 266 | P19623 | |
| VVQQKSEQFMIYNQK | 636 | Q4KWH8 | |
| SEQFMIYNQKQLTRI | 641 | Q4KWH8 | |
| RFQRQKYLSLQQMQE | 56 | Q8N7R0 | |
| QIVYRNVMLENYKNL | 36 | P21506 | |
| QMNRDQLQKFVQYLI | 301 | Q9HCJ5 | |
| KLYRNVMLENYNNLI | 31 | Q5MCW4 | |
| QFHEKIYQMLKNLLQ | 376 | Q14139 | |
| QNLRQEMKLLISFQY | 56 | A0A087X0K7 | |
| QMYQDKLASLKRQLQ | 71 | Q9H7L9 | |
| QEVQLKQQLSLYMDK | 346 | Q9NUQ3 | |
| MLRNNKTIIIKYFLN | 1 | P0C672 | |
| NVQILKLQAKMFTYN | 1886 | O60293 | |
| AQRALQQLKQKMVNY | 186 | Q6IBS0 | |
| LQEYQDKTKAFQIMQ | 2921 | Q14789 | |
| QTYGQQLQKAMLQLL | 606 | P20591 | |
| AYGFRNIQNMILKLK | 346 | Q9UHQ1 | |
| EIILQVFKQLFYMIN | 1676 | Q9ULV0 |